CTMC - a joint venture between Resilience + MD Anderson Cancer Center

At CTMC - a joint venture between Resilience + MD Anderson Cancer Center, our mission is to accelerate the development and manufacturing of cell therapies, ensuring these life-saving treatments reach patients who need them most, as quickly as possible. Our collaboration with Syenex plays a pivotal role in establishing a strong network to deliver comprehensive solutions for our academic and biotech partners. By working together, we can achieve greater impact, faster. #biotech #collaboration #celltherapy

We're #hiring a new Associate Director, Manufacturing in Houston, Texas. Apply today or share this post with your network.

We're #hiring a new Associate Director, Quality Assurance Operations in Houston, Texas. Apply today or share this post with your network.

We're #hiring a new QC Specialist I in Houston, Texas. Apply today or share this post with your network.

We're #hiring a new Manufacturing Associate I/Associate II in Houston, Texas. Apply today or share this post with your network.

We were thrilled to host the incredible team from Hospital Albert Einstein onsite! It was a fantastic opportunity for them to connect with our Process Development and Quality Assurance teams, as well as our colleagues from MD Anderson Cancer Center. #biotech #collaboration #curecancer

We're #hiring a new Project Coordinator in Houston, Texas. Apply today or share this post with your network.

We’re thrilled to unveil our new video, highlighting our cutting-edge 60,000-square-foot facility featuring 14 GMP-certified cleanrooms. Strategically located in the heart of the Texas Medical Center, we’re just 1,200 steps away from MD Anderson Cancer Center, placing us in a prime, patient-adjacent location. Our exceptional team of 93 professionals combines expertise from both academia and industry, driving innovation and excellence. A special thank you to the talented Brandon Martin for bringing this vision to life through his incredible work on the video. #biotech #celltherapy #curecancer

We've come a long way, baby! "If you look back at antibodies, all those 17 innovations happened in silos, and slowly people connected the dots and put things together. But it took a long, long time." ~Jason Bock Jonathan D. Grinstein, PhD, of Inside Precision Medicine, builds on his outstanding coverage of the Meeting on the Mesa with Part 2, where he explores the challenges of scaling cell therapy manufacturing to meet growing demand. While recent advancements are impressive, the current approach of adapting the cell therapy manufacturing model to fit frameworks designed for other modalities falls short. Unlike traditional therapies, cell therapy is uniquely patient-centric, with a complex and individualized supply chain. Addressing these challenges requires more than automation and digitalization—it demands a fundamental rethinking with all the players about how cell therapies are developed and manufactured. #biotech #celltherapy #curecancer https://lnkd.in/efNQijZZ

It takes a village to build great things! CTMC - a joint venture between Resilience + MD Anderson Cancer Center’s Head of Manufacturing, Laine Linden, hosted the Texas Medical Center Innovation Factory team on-site to provide a firsthand, real-world glimpse into the cell therapy manufacturing environment and talent pool. This knowledge will serve our neighbors at Texas Medical Center as they build out their BioPath@TMC aimed to create the skills and job opportunities necessary for Houston’s burgeoning biotech ecosystem.   #biotech #celltherapy #collaboration